Siddhartha Sen, MD, PhD

The primary focus of Dr. Sen's research has been in T-cell based immunotherapy to target malignant melanoma and in the development of novel therapies targeting leukemic stem cells (LSCs) in acute myelogenous leukemia (AML). His specialties include

• Cancer immunology and immunotherapy
• Oncology/cancer stem cell biology and signaling pathways
• In vivo pharmacology studies: Mouse models of leukemia and melanoma
• High throughput screening (HTS)
• Multi-parameter flow cytometry
• Confocal microscopy